Although these differences did not reach statistical significance, likely due to the small sample size, they suggest that the timing of pyrotinib administration may impact clinical outcomes.
← all excerpts
Pyrotinib-assisted whole brain radiotherapy alleviates HER2-positive advanced breast cancer and brain metastases: a prospective study in patients.
1
—
—